This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Christian Oosterbosch, MD
Les Nouveaux Généralistes Liege, Belgium

JAMA. 1995;273(19):1492.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The Review by Dr Baker and colleagues¹ regarding pharmacologic treatment of heart failure is interesting for general practitioners in Belgium. However, I was amazed to find the following recommendation in this article: "Fourth, hospitalize the patient and institute intravenous inotropic therapy such as intravenous dobutamine to increase renal blood flow and facilitate diuresis," but no mention for or against oral therapy with ibopamine. Several recent publications have spoken in favor of oral ibopamine use, even during angiotensin-converting enzyme inhibitor treatment.^2-4 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?